Mitsui Chemicals, Inc. · TSE:4183

Mitsui Chemicals — 1H FY2025 Earnings Presentation

39 slides from Mitsui Chemicals's earnings presentation, Nov 11, 2025

  1. Slide 1: Financial Summary: Results for 1st Half of FY2025 & Outlook for FY2025

    Financial Summary Results for 1st Half of FY2025 & Outlook for FY2025 Mitsui Chemicals, Inc. ＜Remarks＞ November 11, 2025 FY2025 indicates the period from April 1, 2025 to March 31, 2026. This summary contains forward-looking statements about the future plans, strategies, belief and performance of th

  2. Slide 2: Contents

    1. Executive Summary Contents 1）Executive Summary: 1H FY2025 Earnings Announcement ・・・1 2）Executive Summary: 1H FY2025 Financial Results (Operating Income before Special Items) ・・・2 3）Executive Summary: FY2025 Financial Outlook (Operating Income before Special Items) ・・・3 4）Executive Summary: Stock

  3. Slide 3: 1. Executive Summary

    1. Executive Summary Copyright © 2025 Mitsui Chemicals, Inc.

  4. Slide 4: Executive Summary: 1H FY2025 Earnings Announcement

    1) Executive Summary: 1H FY2025 Earnings Announcement ➢ Sales in the specialty chemicals domains have been firm, leading to solid progress in operating income before special items. ➢ As a result of steady progress in business restructuring, we recorded impairment losses in connection with the phenol

  5. Slide 5: Executive Summary: 1H FY2025 Financial Results

    2) Executive Summary: 1H FY2025 Financial Results (Operating Income before Special Items) ➢ Entire Group: Operating income before special items decreased to 44.5 billion yen in 1H FY2025, down 8.3 billion yen (-16%) YoY, primarily due to inventory valuation losses (including time-lag effects of sale

  6. Slide 6: Executive Summary: FY2025 Financial Outlook

    3) Executive Summary: FY2025 Financial Outlook (Operating Income before Special Items) ➢ Entire Group: Operating income before special items is expected to be 110.0 billion yen in FY2025—an increase of 9.0 billion yen (+9%) YoY—which remains unchanged from our previous outlook announced on May 13. ⚫

  7. Slide 7: Executive Summary: Stock Split

    4) Executive Summary: Stock Split（Capital policy aimed at reducing capital costs） ➢ Purpose of the stock split The stock split is intended to expand our company’s investor base with a more affordable environment for investors by lowering the investment unit price of our company’s shares. ➢ Method of

  8. Slide 8: 2. Results for 1st Half of FY2025

    2. Results for 1st Half of FY2025 (April 1, 2025 – September 30, 2025) In accordance with the organizational reform implemented on April 1, 2025, we have revised the segment to which Mitsui Chemicals Asahi Life Materials Co., Ltd. belong from Life & Healthcare Solutions to ICT Solutions as well as t

  9. Slide 9: Trends of Key Market Indicators

    1) Trends of Key Market Indicators FY2025 FY2025 Outlook 2H 1H→ (changes from previous 1H Outlook 2H outlook on May 13) Ophthalmic lens materials market Firm demand Firm demand expected Unchanged Life ＆ Healthcare Solutions Firm demand; inventory level Firm demand expected; inventory level Agrochemi

  10. Slide 10: Major Investment Projects, etc.

    2) Major Investment Projects, etc. Major Investment projects Date Capacity FY23 FY24 FY25 FY26~ Life & Capacity expansion of MR™ High Refractive Index Ophthalmic Lens Material@Japan January.'24 - Capacity expansion of MR™ High Refractive Index Ophthalmic Lens Material@Japan Healthcare (Announced on

  11. Slide 11: Consolidated Financial Highlights

    3-1) Consolidated Financial Highlights (Billions of Yen) () Denotes a minus FY2024 FY2025 Increase Items % 1H 1H (Decrease) Sales revenue 890.4 813.6 (76.8) (9%) Operating income before special items 52.8 44.5 (8.3) (16%) (inc. Equity in earnings) 7.5 8.9 1.4 19% Non-recurring items (6.8) (16.6) (9.

  12. Slide 12: Consolidated Financial Highlights (Operating Income before Special Items)

    3-2) Consolidated Financial Highlights (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials increased due to firm demand. ［+］ ・Agrochemicals increased due to firm demand mainly in the domestic market. ［+］ Volume ・Elastomers increased due to expansion of

  13. Slide 13: Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (compared with corresponding period of FY2024 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Breakdown Segment FY2024 FY2025 Incr. FY2024 FY2025 Incr. Terms of Volume Cos

  14. Slide 14: Life & Healthcare Solutions: Operating Income and Business Overview

    5-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger [+]Sales vo

  15. Slide 15: Mobility Solutions: Operating Income and Business Overview

    5-2) Mobility Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume increa

  16. Slide 16: ICT Solutions: Operating Income and Business Overview

    5-3) ICT Solutions: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume was up due

  17. Slide 17: Basic & Green Materials: Operating Income and Business Overview

    5-4) Basic & Green Materials: Operating Income before Special Items and Business Overview (compared with corresponding period of FY2024 results) Comments Business Overview of FY25.1H [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Elimination of

  18. Slide 18: Non-recurring Items

    6) Non-recurring Items (Billions of Yen) () Denotes a minus FY2024 FY2025 Incr. Items Comments 1H 1H (Decr.) 25.1H Impairment loss (5.6) (12.5) (6.9) Transfer of Equity Interest of PH business joint venture@China* -12.4 25.1H Loss on related business ー (2.2) (2.2) Business restructuring: Kulzer、ARRK

  19. Slide 19: Consolidated Statement of Financial Position

    7) Consolidated Statement of Financial Position (Billions of Yen) () Denotes a minus End of End of Incr. End of End of Incr. Items Items Mar.2025 Sep.2025 (Decr.) Mar.2025 Sep.2025 (Decr.) Current assets 1,041.2 941.7 (99.5) Liabilities 1,183.4 1,123.6 (59.8) Cash and cash equivalents 170.6 168.9 (1

  20. Slide 20: Consolidated Statement of Cash Flows

    8) Consolidated Statement of Cash Flows (Billions of Yen) () Denotes a minus FY2024 FY2025 Incr. Items 1H 1H (Decr.) Ⅰ．Cash flows from operating activities (a) 118.0 127.2 9.2 ( of which Working capital ) 24.8 64.5 39.7 Ⅱ．Cash flows from investing activities (b) (48.3) (57.6) (9.3) ( of which cash i

  21. Slide 21: 3. Outlook for FY2025

    3. Outlook for FY2025 (April 1, 2025 – March 31, 2026) In accordance with the organizational reform implemented on April 1, 2025, we have revised the segment to which Mitsui Chemicals Asahi Life Materials Co., Ltd. belong from Life & Healthcare Solutions to ICT Solutions as well as that of certain o

  22. Slide 22: Highlights of Consolidated Financial Outlook

    1-1) Highlights of Consolidated Financial Outlook (Billions of Yen) () Denotes a minus FY2025 FY2025 Previous FY2024 Incr.(Decr.) Outlook Outlook Items (on May 13) 1st Half Full Year 1st Half Full Year Full Year ％ Full Year Sales revenue 890.4 1,809.2 813.6 1,700.0 (109.2) (6%) 1,770.0 Operating inc

  23. Slide 23: Consolidated Financial Outlook vs Previous Outlook on May 13, 2025

    1-2) Highlights of Consolidated Financial Outlook (vs Previous Outlook on May 13, 2025) (Billions of Yen) () Denotes a minus Operating income before special items FY2025 Comments Segment Previous Outlook [+] denotes profit trigger Outlook Incr.(Decr.) [-] denotes loss trigger (Nov 11) (May 13) [+]Fo

  24. Slide 24: Highlights of Consolidated Financial Outlook (Operating Income before Special Items)

    1-3) Highlights of Consolidated Financial Outlook (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials expected to increase on the back of firm demand. ［+］ ・Agrochemicals expected to increase due to firm demand mainly in the domestic market. ［+］ Volume

  25. Slide 25: Sales Revenue and Operating Income of Outlook by Business Segment

    2) Sales Revenue and Operating Income before Special Items of Outlook by Business Segment (compared with FY2024 results) (Billions of Yen) () Denotes a minus Sales revenue Operating income before special items Breakdown Segment FY2025 FY2025 Terms of FY2024 Incr.(Decr.) FY2024 Incr.(Decr.) Volume Co

  26. Slide 26: Life & Healthcare Solutions: Outlook and Business Overview

    3-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview (compared with FY2024 results) Comments Business Overview of FY25 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger [+]Sales volume Vision care

  27. Slide 27: Mobility Solutions: Outlook and Business Overview

    3-2) Mobility Solutions: Operating Income before Special Items and Business Overview (compared with FY2024 results) Comments Business Overview of FY25 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume increase driven by exp

  28. Slide 28: ICT Solutions: Outlook and Business Overview

    3-3) ICT Solutions: Operating Income before Special Items and Business Overview (compared with FY2024 results) Comments Business Overview of FY25 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume expected to increase, due t

  29. Slide 29: Basic & Green Materials: Outlook and Business Overview

    3-4) Basic & Green Materials: Operating Income before Special Items and Business Overview (compared with FY2024 results) Comments Business Overview of FY25 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger [+]Elimination of plant ・Elimin

  30. Slide 30: Operating Income by Business Segment (2H Outlook vs. 1H of FY2025)

    4) Operating Income before Special Items by Business Segment (2H Outlook vs. 1H of FY2025) (Billions of Yen) () Denotes a minus Operating income before special items Comments FY2025 Segment 2H [+] denotes profit trigger 1H Incr.(Decr.) [-] denotes loss trigger Outlook Life & Healthcare [+]Sales volu

  31. Slide 31: Consolidated Statement of Cash Flows (Outlook)

    5) Consolidated Statement of Cash Flows (Billions of Yen) () Denotes a minus FY2025 FY2024 Outlook Items Incr.(Decr.) 1st Half Full Year(a) 1st Half Full Year(b) Ⅰ．Cash flows from operating activities (a) 118.0 200.5 127.2 200.0 (0.5) Ⅱ．Cash flows from investing activities (b) (48.3) (165.0) (57.6)

  32. Slide 32: 4. Appendix

    4. Appendix 1) Trends in Product Prices 2) Sales Revenue Increase/Decrease (Year on Year) by Business Segment 3) Sales Revenue and Operating Income before Special Items by Business Segment 4) Outline of Business Segments 5) Data Highlights Copyright © 2025 Mitsui Chemicals, Inc.

  33. Slide 33: Trends in Product Prices

    1) Trends in Product Prices (Naphtha prices are Domestic Standard Naphtha Price ) (PE, PP, PH, BPA(Japan): Change in Prices and Raw Materials Prices in Japan / TDI: Chinese Market Price) (ACP) : Asian contract price Year 2022 2023 2024 2025 Month Oct.-Dec. Jan.-Mar. Apr.-Jun. Jul.-Sep. Oct.-Dec. Jan

  34. Slide 34: Sales Revenue Increase/Decrease (Year on Year) by Business Segment

    ２)Sales Revenue Increase/Decrease（Year on Year）by Business Segment (Billions of Yen) () Denotes a minus Sales revenue Breakdown Segment Comments FY2024 FY2025 Incr.(Decr.) Volume Prices 1H 1H Life & Healthcare Volume）Sales of vision care and domestic agrochemicals were firm.[＋] 115.5 115.3 (0.2) 2.9

  35. Slide 35: Sales Revenue and Operating Income by Business Segment

    3) Sales Revenue and Operating Income before Special Items by Business Segment (Billions of Yen) () Denotes a minus Sales revenue* FY2024 FY2025 Segment 2H Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Jul-Sep Outlook Life & Healthcare Solutions 56.6 58.9 57.3 78.9 56.3 59.0 154.7 Mobility Solutions 140.3

  36. Slide 36: Outline of Business Segments

    4) Outline of Business Segments Segment Businesses Main Products Vision Care Materials, Ophthalmic lens materials (MR™, Do Green™), Personal Care Materials, Life & Healthcare Medical materials (taurine), Oral Care, Agrochemicals Solutions Oral care materials (restoratives, adhesives, digital equipme

  37. Slide 37: Data Highlights: Sales Revenue, Operating Income, Cash Flows

    5-1) Data Highlights ～FY19：J-GAAP / FY20～：IFRS () Denotes a minus （Billions of Yen） Total Assets （Billions of Yen） 2,500 Net Sales/Sales Revenue 2,400 2,215.8 2,154.0 2,200 2,068.2 1,879.5 1,935.0 2,000 1,749.7 1,809.2 1,700.0 2,000 1,482.9 1,612.7 1,339.0 1,800 1,500 1,211.7 1,558.1 1,600 1,501.1 1

  38. Slide 38: Data Highlights: Capex, Depreciation, R&D, Net D/E Ratio

    5-2) Data Highlights ～FY19：J-GAAP / FY20～：IFRS （Billions of Yen） 250.0 Capital Expenditure （Billions of Yen） Depreciation & Amortization 207.1 185.7 150.0 200.0 168.0 145.2 154.0 *2 109.0 150.0 *1 92.1 95.2 99.8 93.2 100.0 76.6 84.2 100.0 76.3 61.9 49.5 52.1 50.0 50.0 0.0 0.0 '18 '19 '20 '21 '22 '23

  39. Slide 39: Chemistry for Sustainable World

    Chemistry for Sustainable World Challenge Diversity One Team Copyright © 2025 Mitsui Chemicals, Inc.

Mitsui Chemicals — 1H FY2025 Earnings Presentation on 6ix